NYSE:AVTR - New York Stock Exchange, Inc. - US05352A1007 - Common Stock - Currency: USD
Overall AVTR gets a fundamental rating of 5 out of 10. We evaluated AVTR against 55 industry peers in the Life Sciences Tools & Services industry. While AVTR belongs to the best of the industry regarding profitability, there are concerns on its financial health. AVTR may be a bit undervalued, certainly considering the very reasonable score on growth
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.81% | ||
ROE | 11.73% | ||
ROIC | 5.02% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 9.56% | ||
PM (TTM) | 10.7% | ||
GM | 33.56% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.54 | ||
Debt/FCF | 6.16 | ||
Altman-Z | 1.85 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.12 | ||
Quick Ratio | 0.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.2 | ||
Fwd PE | 11.48 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 13.63 | ||
EV/EBITDA | 12.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NYSE:AVTR (6/9/2025, 12:01:10 PM)
13.33
+0.26 (+1.99%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.2 | ||
Fwd PE | 11.48 | ||
P/S | 1.36 | ||
P/FCF | 13.63 | ||
P/OCF | 11.23 | ||
P/B | 1.49 | ||
P/tB | N/A | ||
EV/EBITDA | 12.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 5.81% | ||
ROE | 11.73% | ||
ROCE | 6.21% | ||
ROIC | 5.02% | ||
ROICexc | 5.18% | ||
ROICexgc | 49.84% | ||
OM | 9.56% | ||
PM (TTM) | 10.7% | ||
GM | 33.56% | ||
FCFM | 9.97% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.54 | ||
Debt/FCF | 6.16 | ||
Debt/EBITDA | 3.14 | ||
Cap/Depr | 35.03% | ||
Cap/Sales | 2.13% | ||
Interest Coverage | 3.38 | ||
Cash Conversion | 77.38% | ||
Profit Quality | 93.12% | ||
Current Ratio | 1.12 | ||
Quick Ratio | 0.75 | ||
Altman-Z | 1.85 |